LeMaitre Vascular/$LMAT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About LeMaitre Vascular
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
Ticker
$LMAT
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
658
ISIN
US5255582018
Website
LMAT Metrics
BasicAdvanced
$1.9B
42.35
$1.97
0.85
$0.72
0.96%
Price and volume
Market cap
$1.9B
Beta
0.85
52-week high
$107.03
52-week low
$71.42
Average daily volume
199K
Dividend rate
$0.72
Financial strength
Current ratio
16.493
Quick ratio
13.646
Long term debt to equity
52.572
Total debt to equity
53.33
Dividend payout ratio (TTM)
33.89%
Interest coverage (TTM)
35.46%
Management effectiveness
Return on assets (TTM)
7.28%
Return on equity (TTM)
13.77%
Valuation
Price to earnings (TTM)
42.347
Price to revenue (TTM)
8.295
Price to book
5.42
Price to tangible book (TTM)
7.61
Price to free cash flow (TTM)
45.645
Dividend yield (TTM)
0.86%
Forward dividend yield
0.96%
Growth
Revenue change (TTM)
13.19%
Earnings per share change (TTM)
30.45%
3-year revenue growth (CAGR)
12.69%
3-year earnings per share growth (CAGR)
16.74%
3-year dividend per share growth (CAGR)
14.33%
What the Analysts think about LMAT
Analyst ratings (Buy, Hold, Sell) for LeMaitre Vascular stock.
LMAT Financial Performance
Revenues and expenses
LMAT Earnings Performance
Company profitability
LMAT News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for LeMaitre Vascular stock?
LeMaitre Vascular (LMAT) has a market cap of $1.9B as of June 06, 2025.
What is the P/E ratio for LeMaitre Vascular stock?
The price to earnings (P/E) ratio for LeMaitre Vascular (LMAT) stock is 42.35 as of June 06, 2025.
Does LeMaitre Vascular stock pay dividends?
Yes, the LeMaitre Vascular (LMAT) stock pays dividends to shareholders. As of June 06, 2025, the dividend rate is $0.72 and the yield is 0.96%. LeMaitre Vascular has a payout ratio of 33.89% on a trailing twelve-month basis.
When is the next LeMaitre Vascular dividend payment date?
The next LeMaitre Vascular (LMAT) dividend payment date is unconfirmed.
What is the beta indicator for LeMaitre Vascular?
LeMaitre Vascular (LMAT) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.